Similarly, Su et al. demonstrated in gliomas that elevated GLUT5 accelerates tumor progression by enhancing fructose uptake, while GLUT5 knockdown markedly suppresses tumor growth 125. The gene discussed is SLC2A5; the disease is central nervous system cancer.